Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCIRN Evaluation of 2010-2011 Seasonal Flu Vaccine
NCT01180621Phase 2Completed
- Sponsor
- Dalhousie University
- Start
- Sep 2010
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by Dalhousie University. Started Sep 2010; status: completed.
02
Drugs
influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01180621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180621.